Edoxaban vs. Warfarin for Stroke Prevention for Patients with Atrial Fibrillation

被引：0
|
作者：
Diener, H. C.
机构：
来源：
AKTUELLE NEUROLOGIE | 2014年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E52 / E52
页数：1
相关论文
共 50 条
  • [21] Should ximelagatran replace warfarin for stroke prevention in patients with atrial fibrillation?
    Donnan, GA
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (06): : 278 - 279
  • [22] Primary Prevention Effectiveness of Warfarin in Patients with ischemic Stroke and Atrial Fibrillation
    不详
    AKTUELLE NEUROLOGIE, 2016, 43 (01) : E11 - E11
  • [23] Direct Oral Anticoagulants vs. Warfarin to Prevent Stroke and Embolic Events in Patients with Atrial Fibrillation and CKD
    Lax, John W.
    Wood, Racheal
    Jonas, Christopher E.
    AMERICAN FAMILY PHYSICIAN, 2019, 99 (07) : 422 - 423
  • [24] COST-EFFECTIVENESS OF EDOXABAN, APIXABAN, RIVAROXABAN AND DABIGATRAN VERSUS WARFARIN FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
    Marchetti, M.
    Liberato, N. L.
    Rognoni, C.
    Quaglini, S.
    HAEMATOLOGICA, 2014, 99 : 487 - 487
  • [25] Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
    Rognoni, Carla
    Marchetti, Monia
    Quaglini, Silvana
    Liberato, Nicola Lucio
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (02) : 149 - 154
  • [26] Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
    Carla Rognoni
    Monia Marchetti
    Silvana Quaglini
    Nicola Lucio Liberato
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 149 - 154
  • [27] Evaluating the potential cost-effectiveness of future anticoagulant drugs vs. warfarin in the prevention of stroke and major bleeds in Atrial Fibrillation patients
    Arant, T
    Sullivan, P
    VALUE IN HEALTH, 2005, 8 (03) : 334 - +
  • [28] Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
    Fu, Chung-Ming
    Li, Lung-Chih
    Lee, Yueh-Ting
    Wang, Shih-Wei
    Hsu, Chien-Ning
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [29] Heterogeneity in Treatment Effect: Dabigatran vs. Warfarin in Patients with Atrial Fibrillation
    Wang, Shirley V.
    Huybrechts, Krista F.
    Fischer, Michael A.
    Franklin, Jessica M.
    Schneeweiss, Sebastian
    Glynn, Robert J.
    Eddings, Wesley
    Gagne, Joshua J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 130 - 131
  • [30] Warfarin vs aspirin for prevention of stroke in nonvalvular atrial fibrillation: Meta-analysis
    Benavente, O
    Hart, RG
    STROKE, 1999, 30 (01) : 241 - 241
12345